Catalyst Wire Dossier Catalyst Wire Dossier

Sekucinumab

Sekucinumab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sekucinumab, covering 2025-01-30 to 2025-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis

See pricing